Skip to main content

Table 2 The level of SPO2, ETCO2, PaCO2, PAW, HR and MAP among three groups

From: Effects of prostaglandin E1 nebulization of ventilated lung under 60%O2 one lung ventilation on patients’ oxygenation and oxidative stress: a randomised controlled trial

 

Group

T1

T2

T3

T4

T5

T6

PaO2 (mm Hg)

P

272 ± 37*

153 ± 32*#

132 ± 29*#

121 ± 27*#

115 ± 35*

153 ± 45*

L

268 ± 58*

128 ± 31*

106 ± 22*

97 ± 20*

112 ± 33*

141 ± 31*

C

465 ± 58

246 ± 73

230 ± 50

185 ± 54

195 ± 42

216 ± 34

SPO2 (%)§

P

99.5 ± 0.7

99.1 ± 1.1

98.2 ± 3.0

98.3 ± 1.5

98.3 ± 1.5

99.4 ± 0.9

L

99.5 ± 0.9

98.8 ± 2.0

98.2 ± 2.1

97.8 ± 2.1

98.5 ± 1.6

99.3 ± 1.2

C

99.6 ± 0.8

99.3 ± 1.4

100.0 ± 0.0

99.9 ± 0.4

100.0 ± 0.0

100.0 ± 0.2

SvO2 (%)

P

75.0 ± 4.1

66.7 ± 9.5*

61.8 ± 11.3*

56.2 ± 9.0*

60.3 ± 12.2*

61.1 ± 7.3*

L

74.8 ± 6.2

67.4 ± 10.5*

61.8 ± 13.0*

58.8 ± 10.7*

60.6 ± 9.1*

60.9 ± 9.1*

C

75.5 ± 3.9

72.4 ± 8.5

68.3 ± 10.7

64.2 ± 11.4

66.5 ± 8.9

66.0 ± 10.7

ETCO2 (mmHg)

P

35.4 ± 5.9

36.8 ± 4.6

35.7 ± 4.1

34.7 ± 4.0

35.1 ± 4.4

34.4 ± 4.4

L

35.6 ± 5.3

36.6 ± 4.2

36.0 ± 4.1

35.3 ± 3.6

35.4 ± 3.8

34.1 ± 4.0

C

35.7 ± 55.3

36.0 ± 4.2

35.4 ± 4.4

34.9 ± 4.4

34.9 ± 4.4

35.4 ± 3.8

PaCO2 (mmHg)

P

42.9 ± 6.0

42.9 ± 5.9

41.5 ± 5.7

40.1 ± 5.8

41.6 ± 6.3

39.5 ± 6.7

L

42.5 ± 4.4

41.5 ± 6.2

41.3 ± 5.3

41.3 ± 5.8

40.4 ± 6.3

39.7 ± 7.0

C

43.1 ± 5.1

42.6 ± 6.2

42.6 ± 5.5

42.0 ± 6.2

41.3 ± 6.8

41.4 ± 5.4

PAW (cmH2O)

P

14.9 ± 3.2

22.5 ± 3.7

23.0 ± 3.4

23.6 ± 4.5

24.3 ± 4.5

24.3 ± 3.9

L

14.4 ± 2.6

23.1 ± 3.9

23.2 ± 4.4

23.7 ± 3.9

24.6 ± 3.9

24.9 ± 4.5

C

15.2 ± 3.0

22.5 ± 3.7

24.2 ± 4.7

24.1 ± 3.8

23.5 ± 3.7

24.2 ± 4.4

HR (bpm)

P

78 ± 14

77 ± 13

78 ± 16

78 ± 15

76 ± 13

71 ± 11

L

74 ± 13

75 ± 12

77 ± 10

77 ± 11

74 ± 13

73 ± 18

C

75 ± 13

74 ± 13

74 ± 13

76 ± 10

75 ± 13

74 ± 10

MAP (mmHg)

P

102 ± 15

96 ± 16

93 ± 16

97 ± 15

99 ± 12

96 ± 11

L

97 ± 12

98 ± 13

93 ± 13

94 ± 13

101 ± 9

98 ± 13

C

99 ± 14

98 ± 12

94 ± 15

101 ± 15

99 ± 10

98 ± 21

  1. T1, post-anesthesia/pre-nebulization; T2, OLV 10 min; T3, OLV 15 min; T4, OLV 30 min; T5, OLV 60 min; T6, OLV 120 min; *p<0.05 compared with group C; #p<0.05 compared with group L; §The SpO2 in patients with hypoxemia was significantly lower than patients in Group P and C